ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,119Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 299

$844K Total Retail Price of All Prescriptions

Rank: 9 out of 299

417 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 417 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 417 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 4,249 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$93 was the average price of a prescription from this provider, compared to $113 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
CARVEDILOL 462 222 1 6
SIMVASTATIN 368 168 2 3
PREDNISONE 342 125 3 13
NIFEDIPINE ER 290 145 4 92
FUROSEMIDE 264 183 5 7
HYDROCODONE-ACETAMINOPHEN 257 75 S3 6 2
OMEPRAZOLE 255 108 7 1
SENSIPAR 249 63 8 79
ALLOPURINOL 240 162 9 45
AMLODIPINE BESYLATE 238 122 10 4
CALCITRIOL 197 104 11 55
LISINOPRIL 178 111 12 5
METOPROLOL TARTRATE 170 90 13 11
SULFAMETHOXAZOLE-TRIMETHOPRIM 141 44 14 78
LOVASTATIN 141 65 14 107
GABAPENTIN 138 47 16 10
WARFARIN SODIUM 133 56 17 8
RENVELA 131 50 18 77
LEVOTHYROXINE SODIUM 125 73 19 14
LANTUS 120 56 20 103
RANITIDINE HCL 103 52 21 60
MIDODRINE HCL 100 25 22 199
DIOVAN 90 34 23 38
TRAMADOL HCL 88 57 24 16
FAMOTIDINE 82 18 25 112
METOCLOPRAMIDE HCL 82 18 25 169
ENALAPRIL MALEATE 81 58 27 83
ATENOLOL 80 46 28 20
ZOLPIDEM TARTRATE 79 47 29 46
CITALOPRAM HBR 77 32 30 58
ROPINIROLE HCL 74 27 31 142
INSULIN SYRINGE 73 23 32 154
TAMSULOSIN HCL 72 42 33 21
PRAVASTATIN SODIUM 65 33 34 25
CIPROFLOXACIN HCL 62 31 35 50
PANTOPRAZOLE SODIUM 61 26 36 36
HUMALOG 58 25 37 177
CYMBALTA 57 13 38 85
ZEMPLAR 54 14 39 142
CALCIUM ACETATE 53 24 40 185
LANTUS SOLOSTAR 53 19 40 173
ZETIA 52 26 42 86
DIPHENOXYLATE-ATROPINE 52 18 42 339
ESCITALOPRAM OXALATE 51 18 44 102
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.